A Study of BMS-986205 Given in Combination With Nivolumab in Patients With Advanced Tumors

Condition:   Advanced Cancer Interventions:   Drug: BMS-986205;   Biological: Nivolumab Sponsor:   Bristol-Myers Squibb Not yet recruiting - verified June 2017 (Source: ClinicalTrials.gov)

from ! Medicine by Alexandros G. Sfakianakis via alwin on Inoreader http://ift.tt/2tr6OKR
via IFTTT